CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

AEG Vision

AEG Vision supports and empowers eyecare professionals to grow their practices while elevating focus on delivering excellent eyecare.

Flexcare Infusion Centers

OrthoLive

OrthoLives mission is to leverage telehealth to streamline orthopedic care so practices and businesses can treat patients quickly.

AA Medical

AA Medical Store improves healthcare around the world by supplying refurbished state-of the-art surgical devices at the best price, with the best warranty, and unmatched service and support.

Skinmedica Inc

Skinmedica Inc is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.